TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Balaxi Pharmaceuticals Limited ( (IN:BALAXI) ) is now available.
Balaxi Pharmaceuticals Limited has submitted a certificate to the National Stock Exchange of India, confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending June 30, 2025. This compliance involves the dematerialization of securities, ensuring that securities are listed on the appropriate stock exchanges, and updating records to reflect the depository as the registered owner, which is crucial for maintaining regulatory standards and operational transparency.
More about Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is engaged in providing a range of healthcare solutions and is listed on the National Stock Exchange of India.
Average Trading Volume: 336,638
Current Market Cap: 551.7M INR
For an in-depth examination of BALAXI stock, go to TipRanks’ Overview page.